Sunesis Pharmaceuticals Reports Positive Initial Results From Phase 2 Small Cell Lung Cancer Trial With SNS-595
January 30th, 2007
Pharmaceuticals, Inc. today announced that the company will advance the small-cell lung cancer trial in treatment-sensitive patients to Stage 2.